Invenomic Capital Management LP
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1769456
BOSTON, MA
Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,819,384
-$2,830,064 QoQ
Shares Held
8,495,551
-29.0% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invenomic Capital Management LP holds $30,164,378 across 2 Biotechnology names. IOVA ranks #1 (98.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
This page
|
8,495,551 | $29,819,384 | |
| 2 | LEXX |
Lexaria Bioscience Corp.
|
442,301 | $344,994 |
All Filings in IOVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,819,384 | 8,495,551 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,649,448 | 11,959,505 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,875,289 | 10,541,608 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,266,820 | 8,294,663 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,281,030 | 5,489,799 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $8,562,930 | 1,053,251 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||